BIG1_HUMAN - dbPTM
BIG1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BIG1_HUMAN
UniProt AC Q9Y6D6
Protein Name Brefeldin A-inhibited guanine nucleotide-exchange protein 1
Gene Name ARFGEF1
Organism Homo sapiens (Human).
Sequence Length 1849
Subcellular Localization Cytoplasm. Cytoplasm, perinuclear region. Golgi apparatus. Golgi apparatus, trans-Golgi network. Nucleus. Nucleus, nucleolus. Nucleus matrix. Membrane. Translocates from cytoplasm to membranes and nucleus upon cAMP treatment.
Protein Description Promotes guanine-nucleotide exchange on ARF1 and ARF3. Promotes the activation of ARF1/ARF3 through replacement of GDP with GTP. Involved in vesicular trafficking. Required for the maintenance of Golgi structure; the function may be independent of its GEF activity. Required for the maturaion of integrin beta-1 in the Golgi. Involved in the establishment and persistence of cell polarity during directed cell movement in wound healing. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways. Inhibits GAP activity of MYO9B probably through competetive RhoA binding. The function in the nucleus remains to be determined..
Protein Sequence MYEGKKTKNMFLTRALEKILADKEVKKAHHSQLRKACEVALEEIKAETEKQSPPHGEAKAGSSTLPPVKSKTNFIEADKYFLPFELACQSKCPRIVSTSLDCLQKLIAYGHLTGNAPDSTTPGKKLIDRIIETICGCFQGPQTDEGVQLQIIKALLTAVTSQHIEIHEGTVLQAVRTCYNIYLASKNLINQTTAKATLTQMLNVIFARMENQALQEAKQMEKERHRQHHHLLQSPVSHHEPESPQLRYLPPQTVDHISQEHEGDLDLHTNDVDKSLQDDTEPENGSDISSAENEQTEADQATAAETLSKNEVLYDGENHDCEEKPQDIVQNIVEEMVNIVVGDMGEGTTINASADGNIGTIEDGSDSENIQANGIPGTPISVAYTPSLPDDRLSVSSNDTQESGNSSGPSPGAKFSHILQKDAFLVFRSLCKLSMKPLSDGPPDPKSHELRSKILSLQLLLSILQNAGPIFRTNEMFINAIKQYLCVALSKNGVSSVPEVFELSLSIFLTLLSNFKTHLKMQIEVFFKEIFLYILETSTSSFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMVEWSKDQYVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPKRGIQYLQEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKFAARYLECNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPTKSSKQNVASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAIRIACIFSIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEILKCISQLELAQLIGTGVKPRYISGTVRGREGSLTGTKDQAPDEFVGLGLVGGNVDWKQIASIQESIGETSSQSVVVAVDRIFTGSTRLDGNAIVDFVRWLCAVSMDELLSTTHPRMFSLQKIVEISYYNMGRIRLQWSRIWEVIGDHFNKVGCNPNEDVAIFAVDSLRQLSMKFLEKGELANFRFQKDFLRPFEHIMKRNRSPTIRDMVVRCIAQMVNSQAANIRSGWKNIFSVFHLAASDQDESIVELAFQTTGHIVTLVFEKHFPATIDSFQDAVKCLSEFACNAAFPDTSMEAIRLIRHCAKYVSDRPQAFKEYTSDDMNVAPEDRVWVRGWFPILFELSCIINRCKLDVRTRGLTVMFEIMKTYGHTYEKHWWQDLFRIVFRIFDNMKLPEQQTEKAEWMTTTCNHALYAICDVFTQYLEVLSDVLLDDIFAQLYWCVQQDNEQLARSGTNCLENVVILNGEKFTLEIWDKTCNCTLDIFKTTIPHALLTWRPNSGETAPPPPSPVSEKPLDTISQKSVDIHDSIQPRSVDNRPQAPLVSASAVNEEVSKIKSTAKFPEQKLFAALLIKCVVQLELIQTIDNIVFFPATSKKEDAENLAAAQRDAVDFDVRVDTQDQGMYRFLTSQQLFKLLDCLLESHRFAKAFNSNNEQRTALWKAGFKGKSKPNLLKQETSSLACGLRILFRMYMDESRVSAWEEVQQRLLNVCSEALSYFLTLTSESHREAWTNLLLLFLTKVLKISDNRFKAHASFYYPLLCEIMQFDLIPELRAVLRRFFLRIGVVFQISQPPEQELGINKQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MYEGKKTKN
------CCCCHHHHC
44.7026074081
7Phosphorylation-MYEGKKTKNMFLTR
-CCCCHHHHCHHHHH
31.0126074081
13PhosphorylationKTKNMFLTRALEKIL
HHHCHHHHHHHHHHH
11.5726074081
23UbiquitinationLEKILADKEVKKAHH
HHHHHCCHHHHHHHH
59.82-
48PhosphorylationLEEIKAETEKQSPPH
HHHHHHHHHCCCCCC
54.0323401153
52PhosphorylationKAETEKQSPPHGEAK
HHHHHCCCCCCCCCC
52.0125159151
63PhosphorylationGEAKAGSSTLPPVKS
CCCCCCCCCCCCCCC
32.80-
70PhosphorylationSTLPPVKSKTNFIEA
CCCCCCCCCCCCEEC
44.9724719451
109PhosphorylationCLQKLIAYGHLTGNA
HHHHHHHCCHHHCCC
9.70-
234PhosphorylationQHHHLLQSPVSHHEP
HHHHHHCCCCCCCCC
27.5229255136
237PhosphorylationHLLQSPVSHHEPESP
HHHCCCCCCCCCCCC
23.6329255136
243PhosphorylationVSHHEPESPQLRYLP
CCCCCCCCCCCCCCC
28.7629255136
248PhosphorylationPESPQLRYLPPQTVD
CCCCCCCCCCHHHHC
31.9527642862
258PhosphorylationPQTVDHISQEHEGDL
HHHHCCCHHHCCCCC
26.5424719451
269PhosphorylationEGDLDLHTNDVDKSL
CCCCCCCCCCCCHHH
40.17-
275PhosphorylationHTNDVDKSLQDDTEP
CCCCCCHHHCCCCCC
27.1422199227
280PhosphorylationDKSLQDDTEPENGSD
CHHHCCCCCCCCCCC
62.8228450419
286PhosphorylationDTEPENGSDISSAEN
CCCCCCCCCCCHHHH
43.2730278072
289PhosphorylationPENGSDISSAENEQT
CCCCCCCCHHHHHHC
28.6130278072
290PhosphorylationENGSDISSAENEQTE
CCCCCCCHHHHHHCH
39.6826657352
296PhosphorylationSSAENEQTEADQATA
CHHHHHHCHHHHHHH
27.2826657352
302PhosphorylationQTEADQATAAETLSK
HCHHHHHHHHHHHCC
22.2928450419
306PhosphorylationDQATAAETLSKNEVL
HHHHHHHHHCCCCCE
31.4427251275
308PhosphorylationATAAETLSKNEVLYD
HHHHHHHCCCCCEEC
40.6322115753
378PhosphorylationQANGIPGTPISVAYT
CCCCCCCCCEEEEEC
16.4626657352
385PhosphorylationTPISVAYTPSLPDDR
CCEEEEECCCCCCCC
9.1826074081
387PhosphorylationISVAYTPSLPDDRLS
EEEEECCCCCCCCEE
44.7426074081
394PhosphorylationSLPDDRLSVSSNDTQ
CCCCCCEECCCCCCC
22.3519664994
396PhosphorylationPDDRLSVSSNDTQES
CCCCEECCCCCCCCC
21.7623401153
397PhosphorylationDDRLSVSSNDTQESG
CCCEECCCCCCCCCC
36.2529255136
400PhosphorylationLSVSSNDTQESGNSS
EECCCCCCCCCCCCC
38.1929255136
403PhosphorylationSSNDTQESGNSSGPS
CCCCCCCCCCCCCCC
33.1923927012
406PhosphorylationDTQESGNSSGPSPGA
CCCCCCCCCCCCCCC
39.9523403867
407PhosphorylationTQESGNSSGPSPGAK
CCCCCCCCCCCCCCC
59.7425627689
410PhosphorylationSGNSSGPSPGAKFSH
CCCCCCCCCCCCHHH
39.2223927012
432AcetylationLVFRSLCKLSMKPLS
HHHHHHHHHCCCCCC
49.227823421
452PhosphorylationPKSHELRSKILSLQL
CCCHHHHHHHHHHHH
36.3526546556
504PhosphorylationVPEVFELSLSIFLTL
CHHHHHHHHHHHHHH
16.9326074081
506PhosphorylationEVFELSLSIFLTLLS
HHHHHHHHHHHHHHH
14.1226074081
510PhosphorylationLSLSIFLTLLSNFKT
HHHHHHHHHHHCHHH
18.2026074081
513PhosphorylationSIFLTLLSNFKTHLK
HHHHHHHHCHHHHHH
43.2526074081
539PhosphorylationLYILETSTSSFDHKW
HHHHHHCCCCCCCHH
35.4920860994
540PhosphorylationYILETSTSSFDHKWM
HHHHHCCCCCCCHHH
28.8620860994
541PhosphorylationILETSTSSFDHKWMV
HHHHCCCCCCCHHHH
34.4820860994
553PhosphorylationWMVIQTLTRICADAQ
HHHHHHHHHHHCCCH
22.7520860994
595PhosphorylationKIAQGRGSQELGMSN
HHHCCCCCHHHCCCC
21.08-
607PhosphorylationMSNVQELSLRKKGLE
CCCHHHHHHHHHHHH
25.9424719451
618PhosphorylationKGLECLVSILKCMVE
HHHHHHHHHHHHHHH
14.8424719451
631PhosphorylationVEWSKDQYVNPNSQT
HHHCCCCCCCCCCCC
16.6027642862
636PhosphorylationDQYVNPNSQTTLGQE
CCCCCCCCCCCCCCC
30.1123312004
638PhosphorylationYVNPNSQTTLGQEKP
CCCCCCCCCCCCCCC
24.6523312004
639PhosphorylationVNPNSQTTLGQEKPS
CCCCCCCCCCCCCCC
22.6623312004
646PhosphorylationTLGQEKPSEQEMSEI
CCCCCCCCHHHHHHC
64.0829255136
651PhosphorylationKPSEQEMSEIKHPET
CCCHHHHHHCCCHHH
35.1030001349
658PhosphorylationSEIKHPETINRYGSL
HHCCCHHHHHCCCCC
28.1830576142
662PhosphorylationHPETINRYGSLNSLE
CHHHHHCCCCCCCCC
13.4321082442
664PhosphorylationETINRYGSLNSLEST
HHHHCCCCCCCCCCC
18.5521082442
667PhosphorylationNRYGSLNSLESTSSS
HCCCCCCCCCCCCCC
38.5123898821
670PhosphorylationGSLNSLESTSSSGIG
CCCCCCCCCCCCCCC
38.5928464451
671PhosphorylationSLNSLESTSSSGIGS
CCCCCCCCCCCCCCC
24.2119690332
672PhosphorylationLNSLESTSSSGIGSY
CCCCCCCCCCCCCCC
31.6128450419
673PhosphorylationNSLESTSSSGIGSYS
CCCCCCCCCCCCCCC
32.4528450419
674PhosphorylationSLESTSSSGIGSYST
CCCCCCCCCCCCCCC
33.9128450419
678PhosphorylationTSSSGIGSYSTQMSG
CCCCCCCCCCCCCCC
17.6228450419
679PhosphorylationSSSGIGSYSTQMSGT
CCCCCCCCCCCCCCC
15.5528450419
680PhosphorylationSSGIGSYSTQMSGTD
CCCCCCCCCCCCCCC
17.5428450419
681PhosphorylationSGIGSYSTQMSGTDN
CCCCCCCCCCCCCCC
21.7628450419
684PhosphorylationGSYSTQMSGTDNPEQ
CCCCCCCCCCCCHHH
28.8226657352
686PhosphorylationYSTQMSGTDNPEQFE
CCCCCCCCCCHHHHH
25.8728450419
757UbiquitinationEFLGDNDKFNKEVMY
HHHCCCCCCCCHHHH
58.03-
796UbiquitinationRLPGEAQKIDRLMEK
CCCCHHHHHHHHHHH
54.33-
849AcetylationQVKNKMTKEQYIKMN
HHHCCCCHHHHHHHH
39.047363985
852PhosphorylationNKMTKEQYIKMNRGI
CCCCHHHHHHHHCCC
12.00-
863UbiquitinationNRGINDSKDLPEEYL
HCCCCCCCCCCHHHH
67.17-
869PhosphorylationSKDLPEEYLSAIYNE
CCCCCHHHHHHHHHH
12.32-
871PhosphorylationDLPEEYLSAIYNEIA
CCCHHHHHHHHHHHC
16.24-
874PhosphorylationEEYLSAIYNEIAGKK
HHHHHHHHHHHCCCC
13.37-
880UbiquitinationIYNEIAGKKISMKET
HHHHHCCCCCCCCHH
37.60-
883PhosphorylationEIAGKKISMKETKEL
HHCCCCCCCCHHHCC
32.4516467138
891PhosphorylationMKETKELTIPTKSSK
CCHHHCCCCCCCCCC
26.4622673903
894PhosphorylationTKELTIPTKSSKQNV
HHCCCCCCCCCCCCC
39.4430576142
896PhosphorylationELTIPTKSSKQNVAS
CCCCCCCCCCCCCCC
45.2922673903
897PhosphorylationLTIPTKSSKQNVASE
CCCCCCCCCCCCCCH
39.5522673903
921PhosphorylationEMEQMAKTAKALMEA
HHHHHHHHHHHHHHH
24.69-
1062PhosphorylationELAQLIGTGVKPRYI
HHHHHHCCCCCCCEE
31.63-
1068PhosphorylationGTGVKPRYISGTVRG
CCCCCCCEEECEECC
14.15-
1072PhosphorylationKPRYISGTVRGREGS
CCCEEECEECCCCCC
10.55-
1079PhosphorylationTVRGREGSLTGTKDQ
EECCCCCCCCCCCCC
20.2923401153
1081PhosphorylationRGREGSLTGTKDQAP
CCCCCCCCCCCCCCC
44.4923927012
1083PhosphorylationREGSLTGTKDQAPDE
CCCCCCCCCCCCCCC
26.6428450419
1130PhosphorylationVAVDRIFTGSTRLDG
EEEEEEECCCCCCCC
28.0524275569
1132PhosphorylationVDRIFTGSTRLDGNA
EEEEECCCCCCCCCH
13.8024275569
1133PhosphorylationDRIFTGSTRLDGNAI
EEEECCCCCCCCCHH
36.2724275569
1220UbiquitinationSLRQLSMKFLEKGEL
HHHHHHHHHHHCCCC
43.34-
12242-HydroxyisobutyrylationLSMKFLEKGELANFR
HHHHHHHCCCCCCEE
60.89-
1224UbiquitinationLSMKFLEKGELANFR
HHHHHHHCCCCCCEE
60.8921890473
1234UbiquitinationLANFRFQKDFLRPFE
CCCEECCHHHHHHHH
47.97-
1249PhosphorylationHIMKRNRSPTIRDMV
HHHHHCCCHHHHHHH
29.9124719451
1352UbiquitinationRLIRHCAKYVSDRPQ
HHHHHHHHHHCCCCH
52.13-
1415PhosphorylationMFEIMKTYGHTYEKH
HHHHHHHHCCCCHHH
11.0325599653
1418PhosphorylationIMKTYGHTYEKHWWQ
HHHHHCCCCHHHHHH
29.0725599653
1419PhosphorylationMKTYGHTYEKHWWQD
HHHHCCCCHHHHHHH
19.8025599653
1533PhosphorylationCTLDIFKTTIPHALL
CEEEEHHHCCCCCCE
21.1427080861
1534PhosphorylationTLDIFKTTIPHALLT
EEEEHHHCCCCCCEE
32.8527080861
1541PhosphorylationTIPHALLTWRPNSGE
CCCCCCEEECCCCCC
21.9329523821
1546PhosphorylationLLTWRPNSGETAPPP
CEEECCCCCCCCCCC
40.4626657352
1549PhosphorylationWRPNSGETAPPPPSP
ECCCCCCCCCCCCCC
48.2529523821
1555PhosphorylationETAPPPPSPVSEKPL
CCCCCCCCCCCCCCC
43.6529255136
1558PhosphorylationPPPPSPVSEKPLDTI
CCCCCCCCCCCCCCC
43.2022115753
1564PhosphorylationVSEKPLDTISQKSVD
CCCCCCCCCCCCCCC
30.1529255136
1566PhosphorylationEKPLDTISQKSVDIH
CCCCCCCCCCCCCCH
33.3829255136
1569PhosphorylationLDTISQKSVDIHDSI
CCCCCCCCCCCHHCC
19.8629255136
1575PhosphorylationKSVDIHDSIQPRSVD
CCCCCHHCCCCCCCC
14.6823927012
1580PhosphorylationHDSIQPRSVDNRPQA
HHCCCCCCCCCCCCC
40.2725159151
1591PhosphorylationRPQAPLVSASAVNEE
CCCCCCCCHHHCCHH
24.9624850871
1593PhosphorylationQAPLVSASAVNEEVS
CCCCCCHHHCCHHHH
25.8321406692
1600PhosphorylationSAVNEEVSKIKSTAK
HHCCHHHHHHHHCCC
31.7624850871
1601UbiquitinationAVNEEVSKIKSTAKF
HCCHHHHHHHHCCCC
60.37-
1641PhosphorylationIVFFPATSKKEDAEN
EEEEECCCCHHHHHH
43.78-
1694UbiquitinationLESHRFAKAFNSNNE
HHHHHHHHHHCCCHH
51.29-
1704PhosphorylationNSNNEQRTALWKAGF
CCCHHHHHHHHHCCC
26.29-
1708AcetylationEQRTALWKAGFKGKS
HHHHHHHHCCCCCCC
39.2119608861
1708UbiquitinationEQRTALWKAGFKGKS
HHHHHHHHCCCCCCC
39.2119608861
1715PhosphorylationKAGFKGKSKPNLLKQ
HCCCCCCCCCCHHHH
63.11-
1721MalonylationKSKPNLLKQETSSLA
CCCCCHHHHHHHHHH
49.6126320211
1725PhosphorylationNLLKQETSSLACGLR
CHHHHHHHHHHHHHH
23.7024732914
1726PhosphorylationLLKQETSSLACGLRI
HHHHHHHHHHHHHHH
27.6624732914

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
883SPhosphorylationKinasePRKACAP17612
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BIG1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BIG1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KAP0_HUMANPRKAR1Aphysical
12571360
BIG2_HUMANARFGEF2physical
10716990
RSP5_YEASTRSP5physical
18832381
NUCL_HUMANNCLphysical
18292223
FBRL_HUMANFBLphysical
18292223
NUP62_HUMANNUP62physical
18292223
LA_HUMANSSBphysical
18292223
NUCL_HUMANNCLphysical
14973189
NUP62_HUMANNUP62physical
14973189

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BIG1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1708, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1569, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-397 ANDSER-1569, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1569, AND MASSSPECTROMETRY.

TOP